CHAPEL HILL, N.C., Feb. 24 /PRNewswire/ -- Though the American Medical Association and others have called for greater transparency surrounding pharmaceutical industry funding of CME and though some big pharma companies have recently moved to better define funding protocol (one even eliminating funding for CME by third-party vendors), 75 - 100 percent of CME programming at most medical associations and teaching hospitals is funded by the bio-pharma industry. As one interviewed VP put it: "No one else will or can support [CME]."
"Educating the Market: Creating Value Through Support of Continuing Medical Education," a just-published benchmarking report from Best Practices, LLC, explores the changing CME landscape in Europe and North America. The research contained in this report examines not only current CME debates in structuring, standardization, and accreditation, but also shows how new delivery methods like E-CME are transforming the face of Continuing Medical Education around the world.
Now available at http://www3.best-in-class.com/rr981.htm, this new 2009 study's sample findings include:
The leading practices, managerial insights and benchmark metrics in "Educating the Market: Creating Value Through Support of Continuing Medical Education" are drawn from interviews and benchmarking surveys with 30 CME leaders from 26 pharmaceutical and biotechnology companies in both Europe and North America. The research also contains quantitative data and insights from seven third-party CME vendors and eight medical associations and teaching hospitals.
A complimentary summary of "Educating the Market: Creating Value Through Support of Continued Medical Education" is available at http://www3.best-in-class.com/rr981.htm. For more information, contact Cameron Tew, Manager of Research and Publishing at Best Practices, LLC at (919) 767-9246 or firstname.lastname@example.org.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for nearly 18 years; our clients include 48 out of the top 50 pharmaceutical companies.
|SOURCE Best Practices, LLC|
Copyright©2009 PR Newswire.
All rights reserved